These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17074844)

  • 1. Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis.
    Bozue J; Cote CK; Moody KL; Welkos SL
    Infect Immun; 2007 Jan; 75(1):508-11. PubMed ID: 17074844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs.
    Bozue JA; Parthasarathy N; Phillips LR; Cote CK; Fellows PF; Mendelson I; Shafferman A; Friedlander AM
    Microb Pathog; 2005 Jan; 38(1):1-12. PubMed ID: 15652290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore Persistence.
    Wang Y; Jenkins SA; Gu C; Shree A; Martinez-Moczygemba M; Herold J; Botto M; Wetsel RA; Xu Y
    PLoS Pathog; 2016 Jun; 12(6):e1005678. PubMed ID: 27304426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.
    Hahn UK; Boehm R; Beyer W
    Vaccine; 2006 May; 24(21):4569-71. PubMed ID: 16157424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction, crystal structure and application of a recombinant protein that lacks the collagen-like region of BclA from Bacillus anthracis spores.
    Liu CQ; Nuttall SD; Tran H; Wilkins M; Streltsov VA; Alderton MR
    Biotechnol Bioeng; 2008 Mar; 99(4):774-82. PubMed ID: 17879302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.
    Vergis JM; Cote CK; Bozue J; Alem F; Ventura CL; Welkos SL; O'Brien AD
    Clin Vaccine Immunol; 2013 Jan; 20(1):56-65. PubMed ID: 23114705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence.
    Welkos SL; Vietri NJ; Gibbs PH
    Microb Pathog; 1993 May; 14(5):381-8. PubMed ID: 8366815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores.
    Cote CK; Rea KM; Norris SL; van Rooijen N; Welkos SL
    Microb Pathog; 2004 Oct; 37(4):169-75. PubMed ID: 15458777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium.
    Steichen C; Chen P; Kearney JF; Turnbough CL
    J Bacteriol; 2003 Mar; 185(6):1903-10. PubMed ID: 12618454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages.
    Bozue J; Moody KL; Cote CK; Stiles BG; Friedlander AM; Welkos SL; Hale ML
    Infect Immun; 2007 Sep; 75(9):4498-505. PubMed ID: 17606596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.
    Gu C; Jenkins SA; Xue Q; Xu Y
    J Immunol; 2012 May; 188(9):4421-31. PubMed ID: 22442442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccination strategies for anthrax prevention].
    Beyer W
    Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):508-24. PubMed ID: 15584433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behaviour of virulent Bacillus anthracis strain AO843 in rabbits.
    Fasanella A; Scasciamacchia S; Garofolo G
    Vet Microbiol; 2009 Jan; 133(1-2):208-9. PubMed ID: 18650035
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine response to infection with Bacillus anthracis spores.
    Pickering AK; Osorio M; Lee GM; Grippe VK; Bray M; Merkel TJ
    Infect Immun; 2004 Nov; 72(11):6382-9. PubMed ID: 15501768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis spores.
    Kuehn A; Kovác P; Saksena R; Bannert N; Klee SR; Ranisch H; Grunow R
    Clin Vaccine Immunol; 2009 Dec; 16(12):1728-37. PubMed ID: 19793896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectives.
    Adamo R
    Expert Rev Vaccines; 2014 Jul; 13(7):895-907. PubMed ID: 24867680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity.
    Brahmbhatt TN; Janes BK; Stibitz ES; Darnell SC; Sanz P; Rasmussen SB; O'Brien AD
    Infect Immun; 2007 Nov; 75(11):5233-9. PubMed ID: 17709408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
    Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.